About this Journal Submit a Manuscript Table of Contents
Journal of Skin Cancer
Volume 2013 (2013), Article ID 189342, 6 pages
http://dx.doi.org/10.1155/2013/189342
Review Article

Merkel Cell Carcinoma: Interdisciplinary Management of a Rare Disease

Department of Otolaryngology—Head and Neck Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria

Received 24 October 2012; Revised 21 December 2012; Accepted 28 December 2012

Academic Editor: Brett A. Miles

Copyright © 2013 Sven Schneider et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Agelli, X. L. Clegg, J. C. Becker, and D. E. Rollison, “The etiology and epidemiology of Merkel cell Carcinoma,” Current Problems in Cancer, vol. 34, no. 1, pp. 14–37, 2010. View at Publisher · View at Google Scholar
  2. M. Agelli and L. X. Clegg, “Epidemiology of primary Merkel cell carcinoma in the United States,” Journal of the American Academy of Dermatology, vol. 49, no. 5, pp. 823–841, 2003.
  3. V. Koljonen, H. Kukko, E. Tukiainen et al., “Incidence of Merkel cell carcinoma in renal transplant recipients,” Nephrology Dialysis Transplantation, vol. 24, no. 10, pp. 3231–3235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. A. Engels, M. Frisch, J. J. Goedert, R. J. Biggar, and R. W. Miller, “Merkel cell carcinoma and HIV infection,” The Lancet, vol. 359, no. 9305, pp. 497–498, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Feng, M. Shuda, Y. Chang, and P. S. Moore, “Clonal integration of a polyomavirus in human Merkel cell carcinoma,” Science, vol. 319, no. 5866, pp. 1096–1100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. J. Allen, W. B. Bowne, D. P. Jaques, M. F. Brennan, K. Busam, and D. G. Coit, “Merkel cell carcinoma: prognosis and treatment of patients from a single institution,” Journal of Clinical Oncology, vol. 23, no. 10, pp. 2300–2309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Medina-Franco, M. M. Urist, J. Fiveash, M. J. Heslin, K. I. Bland, and S. W. Beenken, “Multimodality treatment of merkel cell carcinoma: case series and literature review of 1024 cases,” Annals of Surgical Oncology, vol. 8, no. 3, pp. 204–208, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Heath, N. Jaimes, B. Lemos et al., “Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features,” Journal of the American Academy of Dermatology, vol. 58, no. 3, pp. 375–381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. T. H. Tai, E. Yu, J. Tonita, and J. Gilchrist, “Merkel cell carcinoma of the skin,” Journal of Cutaneous Medicine and Surgery, vol. 4, no. 4, pp. 186–195, 2000. View at Scopus
  10. C. K. Bichakjian, L. Lowe, C. D. Lao et al., “Merkel cell carcinoma: critical review with guidelines for multidisciplinary management,” Cancer, vol. 110, no. 1, pp. 1–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Santamaria-Barria, G. M. Boland, B. Y. Yeap, V. Nardi, D. Dias-Santagata, and J. C. Cusack Jr, “Merkel cell carcinoma: 30-year experience from a single institution,” Annals of Surgical Oncology. In press.
  12. R. Moll, A. Lowe, J. Laufer, and W. W. Franke, “Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies,” American Journal of Pathology, vol. 140, no. 2, pp. 427–447, 1992. View at Scopus
  13. K. G. Lewis, M. A. Weinstock, A. L. Weaver, and C. C. Otley, “Adjuvant local irradiation for Merkel cell carcinoma,” Archives of Dermatology, vol. 142, no. 6, pp. 693–700, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Mojica, D. Smith, and J. D. I. Ellenhorn, “Adjuvant radiation therapy is associated with improved survival in merkel cell carcinoma of the skin,” Journal of Clinical Oncology, vol. 25, no. 9, pp. 1043–1047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Meeuwissen, “The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 31, no. 2, pp. 325–331, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. W. H. Morrison, L. J. Peters, E. G. Silva, C. D. Wendt, K. Kian Ang, and H. Goepfert, “The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 19, no. 3, pp. 583–591, 1990. View at Scopus
  17. E. J. Junor, D. J. Hole, and C. R. Gillis, “Management of ovarian cancer: referral to a multidisciplinary team matters,” British Journal of Cancer, vol. 70, no. 2, pp. 363–370, 1994. View at Scopus
  18. M. R. Stephens, W. G. Lewis, A. E. Brewster et al., “Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer,” Diseases of the Esophagus, vol. 19, no. 3, pp. 164–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. T. Santoso, B. Schwertner, R. L. Coleman, and E. V. Hannigna, “Tumor board in gynecologic oncology,” International Journal of Gynecological Cancer, vol. 14, no. 2, pp. 206–209, 2004. View at Publisher · View at Google Scholar
  20. P. Cohen, A. L. Tan, and A. Penman, “The multidisciplinary tumor conference in gynecologic oncology-does it alter management?” International Journal of Gynecological Cancer, vol. 19, no. 9, pp. 1470–1472, 2009. View at Scopus
  21. T. A. Gatcliffe and R. L. Coleman, “Tumor board: more than treatment planning-a 1-year prospective survey,” Journal of Cancer Education, vol. 23, no. 4, pp. 235–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. M. Pawlik, D. Laheru, R. H. Hruban et al., “On behalf of the Johns Hopkins multidisciplinary pancreas clinic team. Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer,” Annals of Surgical Oncology, vol. 15, no. 8, pp. 2081–2088, 2008. View at Publisher · View at Google Scholar
  23. A. R. Davies, D. A. C. Deans, I. Penman et al., “The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer,” Diseases of the Esophagus, vol. 19, no. 6, pp. 496–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. J. Miller, M. Alam, J. Andersen et al., “Merkel cell carcinoma,” JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. 3, pp. 322–332, 2009. View at Scopus
  25. National Academy Press, Crossing the Quality Chasm: A New Health System for the 21st Century, National Academy Press, Washington, DC, USA, 2001.
  26. E. J. A. Bowles, L. Tuzzio, C. J. Wiese et al., “Understanding high-quality cancer care: a summary of expert perspectives,” Cancer, vol. 112, no. 4, pp. 934–942, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Demaille and P. Cappelaere, “Institutional aspects of concertation in a comprehensive cancer center,” Bulletin du Cancer, vol. 78, no. 1, pp. 37–40, 1991. View at Scopus
  28. Circular relating to the organization of cancer care (22/02/2005). The French Cancer Plan, measure 31.
  29. D. J. Fader, C. G. Wise, D. P. Normolle, and T. M. Johnson, “The multidisciplinary melanoma clinic: a cost outcomes analysis of specialty care,” Journal of the American Academy of Dermatology, vol. 38, no. 5, pp. 742–751, 1998. View at Publisher · View at Google Scholar · View at Scopus